This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Yoshiaki Nose: Innovator in Cancer Therapy
Introduction
Yoshiaki Nose is a prominent inventor based in Fukuoka, Japan. He has made significant contributions to the field of cancer therapy, particularly in renal cell cancer. His innovative work has led to the development of a unique identification marker that responds to interferon therapy.
Latest Patents
Yoshiaki Nose holds a patent for an "Identification marker responsive to interferon therapy for renal cell cancer." This invention provides a method for detecting a genomic DNA of a human gene from a patient with renal cell cancer. The process involves analyzing the DNA sequence to determine gene polymorphism and evaluating the tumor-suppression effect of interferon therapy using this polymorphism as an indicator. He has 1 patent to his name.
Career Highlights
Yoshiaki Nose is associated with Otsuka Pharmaceutical Company, Limited, where he continues to work on innovative solutions in the medical field. His research focuses on improving cancer treatment methodologies and enhancing patient outcomes.
Collaborations
Some of his notable coworkers include Osamu Ogawa and Yoshihiko Hirao, who have collaborated with him on various projects within the pharmaceutical industry.
Conclusion
Yoshiaki Nose's contributions to cancer therapy through his innovative patent demonstrate his commitment to advancing medical science. His work continues to impact the field positively, offering hope for improved treatment options for renal cell cancer patients.